Regeneron, Sanofi asthma drug seen as potential game changer
(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage t...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/KvV8xIOZibo/story01.htm
No comments:
Post a Comment